Abstract
The effects of seven consecutive daily injections of desmethylimipramine (DMI 20 mg/kg) and propranolol (PRO 10 mg/kg) on3H-dihydroalprenolol (3H-DHA) and3H-ketanserin (3H-KET) binding in rat brain were examined. Analyses of saturation binding data using the iterative, nonlinear curve-fitting program LIGAND revealed that PRO increased, while DMI reduced,3H-DHA binding site density in cerebral cortex without altering receptor affinity, as previously reported. DMI reduced3H-KET binding site density without changing affinity, and PRO produced the same effect. In cerebral cortex and probably in hippocampus and striatum, DMI and PRO administered together increased the density of3H-DHA binding sites (beta-adrenergic receptors) and reduced their affinity. This combination of drugs reduced the density of3H-KET binding sites (5-HT2 receptors) in cerebral cortex, but did not change their affinity. These findings indicate a need for additional studies on the interactions of DMI and PRO and related drugs because of implications for the treatment of depressed patients with cardiovascular disorders.
Similar content being viewed by others
References
Adler-Graschinsky E, Carrara AH (1982) Effect of desipramine on propranolol-induced diminution of noradrenaline release by nerve stimulation. J Cardiovasc Pharmacol 4:942–948
Bennett JP, Snyder SH (1976) Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors. Mol Pharmacol 12:373–389
Byland DB, Snyder SH (1976) Beta-adrenergic receptor binding in membrane preparations from mammalian brain. Mol Pharmacol 12:568–580
Carney RM, Rich MW, Te Velde A, Saini J, Clark K, Freeland KE (1987) Prevalence of major depressive disorder in patients receiving beta-blocker therapy versus other medications. Am J Med 83:223–226
Laverty R, Taylor KM (1968) Propranolol uptake into the central nervous system and the effect on rat behavior and amine metabolism. J Pharm Pharmacol 20:605–609
Leysen JE, Niemegeers CJE, Van Nueten JM, Laduron PM (1982) [3H] Ketanserin (R41 468), a selective3H-ligand for serotonin2 receptor binding sites. J Pharmacol Exp Ther 221:301–314
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275
Munson PJ, Rodbard D (1980) LIGAND: a versatile computerized approach for characterization of ligand-binding system. Anal Biochem 107:220–239
Nemeroff CB, Evans DL (1983) Concurrent use of antidepressants and propranolol: case report and theoretical considerations. Biol Psychiatry 18:237–241
Petrie WM, Mafucci RJ, Woolsky RL (1982) Propranolol and depression. Am J Psychiatry 139:92–94
Riva MA, Creese I (1989a) Comparison of two putatively selective radioligands for labeling central nervous systemβ-adrenergic receptors: inadequacy of [3H] dihydroalprenolol. Mol Pharmacol 36:201–210
Riva MA, Creese I (1989b) Reevaluation of the regulation ofβ-adrenergic receptor binding by desipramine treatment. Mol Pharmacol 36:211–218
Scott JA, Crews FT (1986) Down regulation of serotonin2, but not beta-adrenergic receptors during chronic treatment with amitriptyline is independent of stimulation of serotonin2 and betaadrenergic receptors. Neuropharmacology 25:1301–1306
Stockmeier CA, Keller KJ (1989) Serotonin depletion unmasks serotonergic component of [3H] dihydroalprenolol binding in rat brain. Mol Pharmacol 36:903–911
Sugrue MF (1981) Current concepts on the mechanisms of action of antidepressant drugs. Pharmacol Ther 13:219–247
Weinstock M, Weiss C, Gitter S (1977) Blockade of 5-hydroxytrypamine receptors in the central nervous system byβ-adrenoreceptor antagonist. Neuropharmacology 16:273–276
Wolfe BB, Harden TK, Sporn JR, Molinoff PB (1978) Presynaptic modulation of beta-adrenergic receptors in rat cerebral cortex after treatment with antidepressants. J Pharmacol Exp Ther 207:446–457
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mason, G.A., Walker, C.H. & Little, K.Y. Effects of concurrent subchronic treatments with desmethylimipramine and propranolol on beta-adrenergic and serotonin2 receptors in rat brain. Psychopharmacology 110, 110–114 (1993). https://doi.org/10.1007/BF02246958
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02246958